EUVIMEDEUVIMED entdecken
Leserbrief

Safety and efficacy of sodium‐glucose co‐transporter‐2 inhibitors in patients with kidney transplantation and diabetes mellitus

Aparna Yeggalam, Jessica Ann Liebich, Kevin Yu, Ekta Shrestha, Srikanth Nadella, Vaishaliben Ahir, Jennifer Newman, Krista L Lentine iD, Yasar Caliskan iD, Fadee Abu Al Rub iD, Sandeep Dhindsa iD, Stewart G Albert iD

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.15035 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Aparna Yeggalam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Kidney Transplantation, Diabetes Mellitus, Type 2, Symporters. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsKidney TransplantationDiabetes Mellitus, Type 2SymportersHumansHypoglycemic AgentsGlucoseSodiumKidney

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsGlucoseSodiumSymporters

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
  • Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Krista L Lentine, Yasar Caliskan, Fadee Abu Al Rub, Sandeep Dhindsa, Stewart G Albert

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Yeggalam, A., Liebich, J. A., Yu, K., Shrestha, E., Nadella, S., Ahir, V., Newman, J., Lentine, K. L., Caliskan, Y., Abu Al Rub, F., Dhindsa, S., & Albert, S. G. (2023). Safety and efficacy of sodium‐glucose co‐transporter‐2 inhibitors in patients with kidney transplantation and diabetes mellitus. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15035

Vancouver

Yeggalam A, Liebich JA, Yu K, Shrestha E, Nadella S, Ahir V, et al. Safety and efficacy of sodium‐glucose co‐transporter‐2 inhibitors in patients with kidney transplantation and diabetes mellitus. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15035

BibTeX
@article{Yeggalam2023,
  author = {Yeggalam, Aparna and Liebich, Jessica Ann and Yu, Kevin and Shrestha, Ekta and Nadella, Srikanth and Ahir, Vaishaliben and Newman, Jennifer and Lentine, Krista L and Caliskan, Yasar and Abu Al Rub, Fadee and Dhindsa, Sandeep and Albert, Stewart G},
  title = {Safety and efficacy of sodium‐glucose co‐transporter‐2 inhibitors in patients with kidney transplantation and diabetes mellitus},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.15035}
}
Kostenlos starten →